Frankfurt/Main (Germany), March 31, 2008. IonGate Biosciences GmbH will present its SURFE2R Technology for label-free and automatic measurement of transport proteins in a workshop at the SBS 2008, 14th Annual Conference & Exhibition of the Society of Biomolecular Sciences. The meeting takes place in St. Louis, Missouri, USA, on April 6 – 10, 2008. Additionally IonGate will give an exclusive preview of the prototype for the new SURFE2R Workstation 5000.

Immediately at the April 6th opening of the congress, IonGate will host an open workshop on transporters in drug discovery focusing on basics of the SURFE2R Technology and its fast and easy implementation into academic research. Simultaneously the workshop highlights important benefits for the pharmaceutical industry using this technology for high-throughput screening in drug development.

During the SBS meeting a poster will be presented detailing the latest research employing the SURFE2R Technology: Through parallel transporter screening an increase in throughput can be achieved. With the next generation model, the Workstation 5000, to be launched later this year, IonGate paves new ways in industrial automation of transporter screening for the pharmaceutical industry. More detailed information about IonGate and its proprietary technologies will be available at booth no. 929.

Workshop details:
A Novel, Label-Free Analysis Tool for Screening of Transport Proteins
April 6, 2008 | 09:30 am – 12:00 am
St. Louis, Americas Center, Room #241

09:30 – 09:45 Welcome & Introduction
Wolfgang Lerch, IonGate Biosciences, Germany

09:45 – 10:30 Transporter Drug Discovery on a Chip
Béla Kelety, IonGate Biosciences, Germany

10:30 – 11:00 SSM-Based Electrophysiology: A New Tool for Biophysical Research
Klaus Fendler, Max-Planck-Institute of Biophysics, Germany

11:00 – 11:30 Label-Free, High-Quality Screening in Transporter Drug Discovery
Per Sörensen, IonGate Biosciences, Germany

11:30 – 12:00 Discussion and Networking

Contact
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany

phone +49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net

Wolfgang Lerch
President
IonGate Biosciences Inc.
75 Broad Street, 21st Floor
New York, New York 10004
U.S.A.

phone +1.646.405.10 26
fax +1.646.405.10 27
email info@iongate.net

Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de

About IonGate Biosciences GmbH

IonGate Biosciences GmbH develops, produces and markets innovative screening technologies to investigate transporters and is the worldwide leading company in this area.

Transporters are essential for the metabolic functions of the cell, information processing in the entire organism, and also play a fundamental role in the health of humans. Due to their difficult experimental accessibility transporters are underrepresented in current drug screening processes to date. For the first time, IonGate’s SURFE2R One and SURFE2R Workstation 500 provide highly precise functional screening of transporters in higher-throughput and thus positions itself as a leading partner for the pharmaceutical industry. With its SURFE2R Workstation 500 IonGate has created a technological basis for an automated and robust analytical technique. The company provides total system solutions, encompassing disposables and reagents, as well as individual consulting services which include the design of customized applications.

IonGate Biosciences GmbH is a venture capital financed biotechnology company located in Frankfurt/Main, Germany and New York, USA. In addition to the main financier and leading partner Heidelberg Innovation the KfW holds a stake in IonGate. The company was established in 2000 and currently employs more than 30 staff members.

This release was published on openPR.